• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Case Rep . First reported case of delayed-type hypersensitivity reaction to non-hyaluronic acid Polycaprolactone dermal filler following COVID-

tetano

tetano

Editor, Senior Moderator
Clin Case Rep


. 2022 Feb 6;10(2):e05343.
doi: 10.1002/ccr3.5343. eCollection 2022 Feb.
First reported case of delayed-type hypersensitivity reaction to non-hyaluronic acid Polycaprolactone dermal filler following COVID-19 vaccination: A case report and a review of the literature


Yasamin Kalantari[SUP] 1 [/SUP], Afsaneh Sadeghzadeh-Bazargan[SUP] 2 [/SUP], Zeinab Aryanian[SUP] 3 4 [/SUP], Parvaneh Hatami[SUP] 3 [/SUP], Azadeh Goodarzi[SUP] 2 5 [/SUP]



Affiliations

Abstract

Cases of filler reactions after COVID-19 vaccination have been reported. Here, we present the first case of delayed-type reaction (DTR) to non-hyaluronic acid Polycaprolactone dermal filler after the second dose of Sinopharm COVID-19 vaccine which was improved with administration of topical and intralesional steroids.

Keywords: COVID‐19; COVID‐19 vaccines; adverse effects; augmentation; case report; coronavirus; cosmetic; cosmetic filler; delayed‐type reaction; dermal fillers; hyaluronic acid; hyaluronic acid fillers; non‐hyaluronic acid fillers; review; side effects; swelling; vaccination.
 
You must log in or register to reply here.
Back
Top Bottom